Dr. Carol Wysham, MD (she/her) is an Endocrinologist in Spokane, WA with over 17 years of experience. What is your opinion of Dr. Carol Wysham, MD? Rate this provider below so other people can make informed decision.
Over 17 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Carol Wysham, MD has received over $1,586,751 which includes payments from the following companies:
$616,898.75 from sanofi-aventis U.S. LLC
$294,214.03 from Janssen Pharmaceuticals, Inc
$269,460.48 from Novo Nordisk Inc
$130,712.31 from AstraZeneca Pharmaceuticals LP
$113,243.12 from LILLY USA, LLC
$41,067.77 from Boehringer Ingelheim Pharmaceuticals, Inc.
$38,644.92 from Novo Nordisk AS
$25,306.94 from Abbott Laboratories
$10,739.30 from Janssen Scientific Affairs, LLC
$10,538.71 from INSULET CORPORATION
$10,333.97 from AstraZeneca UK Limited
$5,978.46 from Janssen Global Services, LLC
$5,692.16 from Dexcom, Inc.
$4,150.38 from Becton, Dickinson and Company
$2,942.83 from E.R. Squibb & Sons, L.L.C.
$2,675.27 from MannKind Corporation
$914.59 from Medtronic MiniMed, Inc.
$387.25 from Amgen Inc.
$331.06 from Lexicon Pharmaceuticals, Inc.
$272.17 from AbbVie, Inc.
Payments received by Dr. Carol Wysham, MD were from the following categories:
$881,178.29 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!